Non-Small Cell Lung Cancer Therapy
Study results from J.A. Treat et al provide new insights into non-small cell lung cancer therapy
Published in Cancer Weekly, March 23rd, 2010
Scientists discuss in 'A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer' new findings in non-small cell lung cancer. "Paclitaxel-carboplatin is used as the standard regimen for patients with advanced or metastatic non-small-cell lung cancer (NSCLC). This trial was designed to compare gemcitabine + carboplatin or gemcitabine + paclitaxel to the standard regimen," scientists writing in the journal Annals of Oncology report.
"A total of 1135 chemonaive patients with stage IIIB or IV NSCLC were randomly allocated...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2010-03-23)
More Articles from Cancer Weekly
- American Cancer Society
Improvements needed in genomic test result discussions - American Cancer Society
Study finds cancer mortality has declined since initiation of 'war on cancer' - Columbia University Medical Center
Acupuncture may relieve joint pain caused by some breast cancer treatments - EQ Biosciences, Inc.
Supplement blocks the initiation of breast cell mutations by estrogens - Journal of the National Cancer Institute
High weight associated with risk of colorectal tumors without microsatellite instability - University of Leicester
MRC scientists announce advance in understanding body's natural defenses - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
